Philipp Jost

24PUBLICATIONS
146CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsHaematological tumoursPredictive and prognostic markersHuman rights and justice issues (excl. law)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 10, 2026
Reference-Free Microsatellite Instability Detection from Tumor Sequencing Using Intrasample Variability Modeling.

|Jan 21, 2026
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.

Deepti Agrawal, Katarina Cisarova, Sebastian Vosberg

|Nov 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Ulrike Höckendorf, Sayantanee Dutta, Arnold Kloos

|Aug 29, 2024
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update.

Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat

|Jun 11, 2024
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.

Heikki Joensuu, Annette Reichardt, Mikael Eriksson

|Nov 20, 2023
Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.

Jakob M Riedl, Florian Moik, Tamara Esterl

Pageof 4

Frequent Collaborators

4 joint publications

Thomas Kaufmann

4 joint publications

Deepti Agrawal

3 joint publications

Sebastian Bauer

3 joint publications

Stefan Fröhling